1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myelodysplastic syndromes (MDS)
    Journal Article

    Klimek, V.
    Best Practice and Research: Clinical Haematology (2015)

    Fulltext@MSK | Save
  • Immunotherapeutic approaches in prostate cancer: Combinations and clinical integration
    Journal Article

    Slovin, S. F.
    American Society of Clinical Oncology Educational Book (2015)

    Fulltext@MSK | Save
  • Genetic-engineering strategies to enhance CAR T-cell therapy efficacy against PD-L1 expressing lung adenocarcinoma and mesothelioma
    Meeting Abstract

    Cherkassky, L.; Morello, A.; Villena-Vargas, J.; Mayor, M.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Targetable cancer-associated antigens for immunotherapy in malignant pleural mesothelioma (MPM) — Mesothelin, CA125 and WT-1
    Meeting Abstract

    Ujiie, H.; Eguchi, T.; Mayor, M.; Kadota, K.; Travis, W. D.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin-targeted CAR T-cell therapy for the treatment of heterogeneous antigen-expressing lung adenocarcinoma
    Meeting Abstract

    Morello, A.; Villena-Vargas, J.; Mayor, M.; Bograd, A. J.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-targeted radiation therapy helps overcome the solid tumor T-cell infiltration barrier and promotes mesothelin CAR T-cell therapy
    Meeting Abstract

    Mayor, M.; Villena-Vargas, J.; De Biasi, A.; Morello, A.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma
    Meeting Abstract

    Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Targeting CD99 in T-cell neoplasms
    Meeting Abstract

    Tavakkoli, M.; Lee, D. H.; Chung, S. S.; Park, C. Y.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • CHRONOS-3: A phase III, randomized, double-blind, placebocontrolled study evaluating the efficacy and safety of phosphatidylinositol-3 kinase (PI3K) alpha/delta inhibitor copanlisib in combination with rituximab in patients with relapsed indolent B-c
    Meeting Abstract

    Zinzani, P. L.; Gerecitano, J. F.; Giurescu, M.; Ito, R.; Mueller, K.; Childs, B. H.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save